MarketPeel
Insider Trading Intelligence
DE

Dov Elefant

CLRB
CHIEF FINANCIAL OFFICER · CELLECTAR BIOSCIENCES, INC. · CIK 0001326487
FILING MIX · LIFETIME100%/0%
BUYS
23
SELLS
0
TOTAL VALUE
$62.1K
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
456,122
AVG SELL PX
TRADE KIND
SHOWING 23 / 23
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Dov Elefant, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%+1.75%-3.46%+5.22%+7.37%
14d3+66.67%+2.64%-1.36%+4.01%+9.06%
30d3+66.67%+17.73%+0.02%+17.71%+30.98%
60d3+66.67%+11.82%+3.27%+8.55%+19.00%
90d3+0.00%-11.78%+7.99%-19.77%-13.02%
180d3+66.67%+34.49%+15.68%+18.81%+55.22%
1y3+66.67%+1.92%+32.92%-31.01%+1.51%
2y3+0.00%-73.16%+23.24%-96.40%-96.36%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CLRB · 422,000 shares · as of Jan 25, 2022
0107,500215,000322,500430,00020212022SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 23 buys / 0 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
34,12234,122Mar 19, 2026Mar 27, 2026View →
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
169,000169,000Feb 19, 2026Feb 20, 2026View →
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
173,000173,000Feb 19, 2026Feb 20, 2026View →
FEMY
FEMASYS INC
PURCHASE
Chief Financial Officer
34,12234,122Nov 7, 2025Nov 12, 2025View →
FEMY
FEMASYS INC
PURCHASE
Chief Financial Officer
34,12234,122Nov 7, 2025Nov 12, 2025View →
FEMY
FEMASYS INC
PURCHASE
Chief Financial Officer
34,12234,122Nov 7, 2025Nov 12, 2025View →
FEMY
FEMASYS INC
PURCHASE
Chief Financial Officer
Nov 7, 2025Nov 12, 2025View →
FEMY
FEMASYS INC
PURCHASE
Chief Financial Officer
38,82838,828Aug 27, 2025Aug 28, 2025View →
FEMY
FEMASYS INC
PURCHASE
Chief Financial Officer
38,82858,436Aug 27, 2025Aug 28, 2025View →
FEMY
FEMASYS INC
PURCHASE
Chief Financial Officer
19,608$1.02$20.0K19,608Jun 2, 2025Jun 4, 2025View →
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
114,300114,300Jan 28, 2025Jan 30, 2025View →
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
72,04572,045Jan 28, 2025Jan 30, 2025View →
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
84,00084,000Feb 1, 2024Feb 2, 2024View →
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
105,200105,200Jul 3, 2023Jul 3, 2023View →
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
204,700204,700Jul 3, 2023Jul 3, 2023View →
FEMY
FEMASYS INC
PURCHASEGRANT
Stock grant
100,000100,000Feb 28, 2022Mar 1, 2022View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
422,000422,000Jan 25, 2022Jan 27, 2022View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
430,000430,000Mar 4, 2021Mar 5, 2021View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASE
Chief Financial Officer
7,407$1.35$10.0K11,755Dec 28, 2020Dec 28, 2020View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASE
Chief Financial Officer
4,348$1.15$5.0K4,348Jun 5, 2020Jun 8, 2020View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASE
Chief Financial Officer
2,174$0.01$222,174Jun 5, 2020Jun 8, 2020View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
10,000$2.71$27.1K10,000Feb 3, 2020Feb 4, 2020View →
CLRB
CELLECTAR BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
10,00010,000Feb 3, 2020Mar 5, 2020View →
Other insiders · CLRB
Loading peer insiders…
About this filer
CIK 0001326487
ROLE
Chief Financial Officer
PRIMARY
CLRB
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001326487DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback